Mayo Clinic Talks

Host: Darryl S. Chutka, M.D. Guest: Stan Henkin, M.D. Peripheral arterial disease is a manifestation of atherosclerosis and becomes more common with advancing age. In its early stages, it can be quite difficult to diagnose. Although claudication is the most classic symptom, many remain asymptomatic, especially if they have limited ability to ambulate. Although risk factor modification is important in disease management, overall treatment options have been somewhat disappointing. How can we diagnose PAD early and are there advantages in recognizing the disease in an early stage? What are the best ways to establish a diagnosis and what treatment options do we have available? Our topic for this podcast is “Peripheral Arterial Disease” and these are questions I’ll asking my guest, Stan Henkin, M.D., a vascular medicine specialist from the Department of Cardiovascular Medicine at the Mayo Clinic. Mayo Clinic Talks: Vascular Medicine Series | Mayo Clinic School of Continuous Professional Development Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts

Host: Darryl S. Chutka, M.D. Guest: Ana I. Casanegra, M.D., M.S. For many decades, we really only had one option for providing chronic anticoagulation, warfarin. We learned how to manage the many drug and food interactions, frequently changing the warfarin dose as we tried to keep our patients in therapeutic range. Now we have a variety of choices with the direct-acting oral anticoagulants, or DOAC’s. How do the newer agents compare to warfarin in effectiveness? Are they really safer than warfarin? Do they ever require any monitoring? What’s the latest on reversing the anticoagulant effect? I’ll be discussing these topics and more with my guest, Ana I. Casanegra, M.D., M.S., a vascular medicine specialist at the Mayo Clinic. The topic for this podcast is “How to Choose Your Anticoagulant”. Mayo Clinic Talks: Vascular Medicine Series | Mayo Clinic School of Continuous Professional Development Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts

Host: Darryl S. Chutka, M.D. Guests: Christopher Francois, M.D. The risk of thoracic aortic dissection increases as the diameter of the aorta widens. A diameter greater than 5 cm is associated with an increased risk of dissection in the general population. Patients with Marfan Syndrome have defective connective tissue and dissection commonly occurs with diameters less than 5 cm. Other health conditions associated with aortic dilation and potential dissection include Ehlers Danlos and those with bicuspid aortic valves. It therefore becomes extremely important to accurately assess the aorta. Fortunately, we now have a variety of imaging tools available and several of these tools are relatively new. My guest for today’s podcast is Dr. Christopher Francois, from the Department of Diagnostic Radiology at the Mayo Clinic and he’ll bring us up to date regarding the most recent imaging techniques as we continue our series on vascular medicine. We’ll discuss who’s at risk for an aortic aneurysm, when some of the more traditional imaging is indicated and when we should consider some of the newer imaging tools. Mayo Clinic Talks: Vascular "What's Circulating" | Mayo Clinic School of Continuous Professional Development Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts

Host: Darryl S. Chutka, M.D. Guests: Thais D. Coutinho, M.D., and Kristen A. Sell-Dottin, M.D. Genetic factors predispose selected individuals to hereditary aortic aneurysms leading to aortic dilation and potential dissection. They can be seen in a variety of known genetic syndromes, and they differ from aortic aneurysms associated with aging and chronic, uncontrolled hypertension. Early recognition is critical in the management of these patients in preventing serious, often life-threatening aortic dissection. How common are hereditary aortic aneurysms? When and how should we screen patients for this condition? Is a genetic consultation recommended? When should we involve a vascular surgeon when at risk patients are identified? These are some of the questions I’ll be asking my guests, Thais D. Coutinho, M.D., a cardiologist and cardiac surgeon, Kristen A. Sell-Dottin, M.D., both from the Mayo Clinic. We’ll be discussing “Hereditary Aortic Aneurysms and Dissection” as part of our podcast series on “Peripheral Vascular Disease”. Mayo Clinic Talks: Vascular "What's Circulating" | Mayo Clinic School of Continuous Professional Development Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts

Host: Darryl S. Chutka, M.D. Guest: Jacob K. Dey, M.D. Bell’s Palsy is the most common cause of 7th cranial nerve dysfunction and clinically, it has a relatively abrupt onset resulting in unilateral facial paralysis. Fortunately, the majority of patients recover completely without treatment. Unfortunately, in some cases, the facial paralysis is persistent, and surgical intervention may be indicated to help restore facial symmetry. When do patients reach maximum improvement in their facial asymmetry? What is facial synkinesis? What are the various surgical options and how is it determined which one is best for the patient? The topic for this podcast is “Correcting Facial Paralysis Associated with Bell’s Palsy” and these are some of the questions I’ll be asking my guest, facial plastic surgeon, Jacob K. Dey, M.D., from the Division of Facial Plastic & Reconstructive Surgery at the Mayo Clinic. Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts

Host: Darryl S. Chutka, M.D. Guest: Gregory A. Poland, M.D. Measles is a viral illness that very recently was considered rare in this country but unfortunately has seen a resurgence in recent times. It’s highly contagious and can lead to severe complications including encephalitis and potentially death. There is an effective vaccine and it’s typically administered along with mumps and rubella as the MMR. The vaccine was introduced in the 1960’s and resulted in a dramatic reduction in the incidence of measles. Despite overwhelming evidence of the vaccine’s safety and efficacy, vaccine hesitancy has resulted in measles outbreaks in communities with lower immunization rates. The topic for today’s podcast is measles and my guest is Greg A. Poland, M.D., a general internist and vaccine research specialist at the Mayo Clinic. We’ll discuss the clinical manifestations of measles, the measles vaccine, vaccine hesitancy and how we as clinicians can most effectively educate our patients about measles. Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts Are you a medical professional, ready to ignite your passion and fuel your success? Join us October 23rd-25th in beautiful Pasadena, California or via livestream for GRIT, where innovation meets inspiration. GRIT in Medicine: Growth, Resilience, Inspiration & Tenacity 2025 will empower healthcare professionals with skills and resources to excel through productivity, personal development, and professional community. Leaders in business and healthcare will present evidence-based strategies and practical tips and tools to promote professional and personal well-being, and you’ll leave encouraged and energized for excellence. Visit ce.mayo.edu/GRIT2025 by September 1st with the discount code GRIT2025 to save $100 on registration. See you soon for GRIT!

Host: Darryl S. Chutka, M.D. Guest: Stacy D. D’Andre, M.D. When we diagnose a patient with cancer, we typically focus on finding the most effective treatment for that malignancy: surgery, radiotherapy, chemotherapy, or immunotherapy. However, to a patient, the diagnosis of cancer means much more. Patients commonly experience fear and anxiety just from receiving the diagnosis. Other symptoms may include insomnia, depression, pain, and symptomatic effects from the treatment including nausea, loss of appetite and fatigue to name just a few. The Mayo Clinic Comprehensive Cancer Center has developed an integrative approach to help patients manage the variety of symptoms associated with malignancy. It centers around a multi-disciplinary team which assesses each patient individually and incorporates a variety of complementary treatments as well as physical and emotional support. It also includes nutrition and dietary supplement counseling and recommendations regarding exercise and movement. In this podcast, we’ll learn more about this fascinating approach to treating patients with cancer as we discuss “Integrative Oncology” with my guest, Stacy D. D’Andre, M.D., from the Department of Oncology at the Mayo Clinic. Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts Are you a medical professional, ready to ignite your passion and fuel your success? Join us October 23rd-25th in beautiful Pasadena, California or via livestream for GRIT, where innovation meets inspiration. GRIT in Medicine: Growth, Resilience, Inspiration & Tenacity 2025 will empower healthcare professionals with skills and resources to excel through productivity, personal development, and professional community. Leaders in business and healthcare will present evidence-based strategies and practical tips and tools to promote professional and personal well-being, and you’ll leave encouraged and energized for excellence. Visit ce.mayo.edu/GRIT2025 by September 1st with the discount code GRIT2025 to save $100 on registration. See you soon for GRIT!

Host: Darryl S. Chutka, M.D. Guest: Melinda J. Hahm Bariatric surgery is very likely the most effective method for long-term weight loss. It’s not unusual for patients to lose well over 50% of their excess body weight. As a result, a variety of chronic health risks are reduced including diabetes, cardiovascular disease, sleep apnea, hypertension to name just a few. Exercise, associated with bariatric surgery is important to help achieve and maintain long-term weight loss and help prevent regaining the weight lost. The topic for this podcast is “Exercise and Bariatric Surgery” and my guest is Melinda J. Hahm, an exercise physiologist from the Mayo Clinic. Some of the topics we’ll discuss include the benefits of exercise associated with bariatric surgery, when patients should start an exercise program in relation to their surgery and what type of exercise is best to help maintain weight loss. Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts

Host: Darryl S. Chutka, M.D. Guest: Eric J. Moore, M.D. Salivary gland tumors can be benign or malignant, as well as primary or metastatic. Malignant salivary gland tumors usually present after the 6th decade, whereas benign lesions tend to occur a bit earlier, usually in the 4th to 5th decades. An interesting statistic is that the vast majority of salivary gland tumors occur in the parotid, only about 10% occur in the submandibular salivary gland and less than 4% in the minor salivary glands. Fortunately, most parotid tumors are benign. Previous radiation as well as occupational exposure to silica and nitrosamines have been linked to malignant parotid tumors. What should a primary care clinician do when we discover a mass in the parotid gland? What imaging studies are helpful? What treatment is available and what happens if the tumor recurs? These are all questions I’ll be asking my guest, Eric J. Moore, M.D., Chair of Otolaryngology and Head and Neck Surgery at the Mayo Clinic as we discuss “Parotid Gland Tumors”. Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts

Host: Darryl S. Chutka, M.D. Guest: Sunanda V. Kane, M.D. Most people who develop inflammatory bowel disease are diagnosed before the age of 30. In women, this often occurs during the middle of their reproductive years. Some with inflammatory bowel disease choose to avoid pregnancy, usually due to misconceptions about pregnancy risks. Yet if properly managed, women can experience a normal, uneventful pregnancy and deliver a healthy child. What effect does inflammatory bowel disease have on fertility? Do patients have a greater chance of a normal pregnancy if the bowel disease is in remission? How can patients minimize the risk of inflammatory bowel disease flares during pregnancy and are the pharmacologic therapies commonly used to treat inflammatory bowel disease safe to use during pregnancy? These are some of the questions I’ll ask my guest, Sunanda V. Kane, M.D., from the Division of Gastroenterology and Hepatology at the Mayo Clinic as we discuss “Inflammatory Bowel Disease and Pregnancy”. https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts

Host: Darryl S. Chutka, M.D. Guests: Amanda M. Johnson, M.D., and Victor G. Chedid, M.D., M.S. This podcast continues our series on inflammatory bowel disease. The topic is important and timely: “Inflammatory Bowel Disease in Special Populations: The Elderly, the Obese and the LGBTQ Patient.” It’s critical that we broaden our perspective in addressing the unique challenges faced by these often-unrecognized population groups. How common is the presentation of inflammatory bowel disease in those over 65? How does age affect the treatments commonly used? Does obesity alter the disease presentation or activity and what are some of the unique challenges our LGBTQ patients face with inflammatory bowel disease? These are just some of the questions I’ll be asking my guests, Amanda M. Johnson, M.D., and Victor G. Chedid, M.D., M.S., both gastroenterologists at the Mayo Clinic. https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts

Host: Darryl S. Chutka, M.D. Guest: Konstantinos A. Papadakis, M.D. Due to the complexity and new pharmacologic options for the management of inflammatory bowel disease, patients often have their care provided by a gastroenterologist. They may not see their primary care provider as often as in the past and some of their preventive health maintenance may not get performed. Are patients receiving primarily specialty care still receiving good health maintenance? Are we aware that patients with inflammatory bowel disease have some unique needs regarding their preventive health maintenance and some of the recommendations are different than the general population? These are questions I’ll be asking my guest, gastroenterologist Konstantinos A. Papadakis, M.D., from the Mayo Clinic as we discuss “Health Maintenance in Inflammatory Bowel Disease” as part of our ongoing series on Inflammatory Bowel Disease. https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts

Host: Darryl S. Chutka, M.D. Guests: Darrell S. Pardi, M.D., and Laura E. Raffals, M.D. Pouchitis is a relatively common complication in patients who have ulcerative colitis and have had a proctocolectomy with an ileal pouch-anal anastomosis. It represents inflammation of the ileal pouch and symptoms may include increased stool frequency, cramps, fecal urgency and occasionally bloody stools. The diagnosis is usually suspected from clinical symptoms and confirmed with endoscopy. Are there risk factors for the development of pouchitis? Is an endoscopy necessary for a diagnosis? How should patients be treated and how effective is treatment? These are some of the questions I’ll be asking my guests, Darrell S. Pardi, M.D., and Laura E. Raffals, M.D., both gastroenterologists at the Mayo Clinic. We’ll be discussing “Pouchitis” as part of our podcast series on “Inflammatory Bowel Disease”. https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts

Host: Darryl S. Chutka, M.D. Guests: Darrell S. Pardi, M.D., and Laura E. Raffals, M.D. Microscopic colitis is one of the lesser-known members of the inflammatory bowel disease family. Symptoms include chronic, frequent diarrhea and fecal urgency. It’s usually suspected from the patient’s clinical symptoms and diagnosis is established by colonoscopy with biopsy. Biopsy is necessary as the colonic mucosa appears normal at endoscopy. A specific cause isn’t known but it can be associated with several medications. Although it’s not typically a life-threatening condition, it can lead to weight loss and potentially dehydration. How does microscopic colitis differ from ulcerative colitis or Crohn’s Disease? Who’s at risk of developing it? Since these patients usually present to primary care providers, when should we suspect it? How is it managed, and can it be cured? These are some of the questions I’ll be asking my guests, Darrell S. Pardi, M.D., and Laura E. Raffals, M.D., both gastroenterologists at the Mayo Clinic. We’ll be discussing “Microscopic Colitis” as part of our ongoing series of podcasts on “Inflammatory Bowel Disease”. https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts

Host: Darryl S. Chutka, M.D. Guest: Edward V. Loftus JR, M.D. Inflammatory Bowel Disease is somewhat of an umbrella term for a group of chronic inflammatory conditions of the GI tract. The most common types include ulcerative colitis and Crohn’s Disease. While there are similarities between the two, there are also differences. For many individuals with inflammatory bowel disease, it’s only a mild illness. Unfortunately for some, it can lead to severe disability and potentially life-threatening complications. What are the similarities and differences between ulcerative colitis and Crohn’s? When should we suspect a patient has an inflammatory bowel disease? What’s the best way to establish a diagnosis and finally, what treatment options do we have? These are just some of the questions I’ll be asking my guest, Edward V. Loftus JR, M.D., from the Division of Gastroenterology and Hepatology at the Mayo Clinic as we discuss “Inflammatory Bowel Disease and Its Treatment”. https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts

Host: Darryl S. Chutka, M.D. Guests: David H. Bruining, M.D., and Nayantara Coelho-Prabhu, M.B.B.S. An early diagnosis of inflammatory bowel disease is important in preventing long-term complications. Prompt treatment can improve quality of life, reduce the likelihood of hospitalizations, and help maintain remissions. However, establishing a diagnosis is often challenging due to the nonspecific and fluctuating nature of symptoms. Inflammatory bowel disease can also mimic other GI conditions. In addition, diagnostic confirmation usually requires a combination of blood tests, imaging, endoscopy, and histological analysis, making the process both time consuming and complex. The topic for today's podcast is “Diagnosing Inflammatory Bowel Disease and Monitoring Modalities” and my guests are David H. Bruining, M.D., and Nayantara Coelho-Prabhu, M.B.B.S., from the Division of Gastroenterology and Hepatology at the Rochester campus of the Mayo Clinic. https://ce.mayo.edu/content/mayo-clinic-talks-inflammatory-bowel-disease Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts

Host: Denise M. Dupras, M.D., Ph.D. Guest: Melissa Davis, Ph.D., Director of the Institute of Translational Genomic Medicine at Morehouse School of Medicine In this insightful episode, Dr. Melissa Davis delves into the profound influence of genetic ancestry on health outcomes and disparities. Her pioneering work in disparities genomics sheds light on how biological determinants intersect with systemic marginalization to exacerbate cancer health disparities. Dr. Davis discusses groundbreaking research linking ancestry to tumor biology, particularly in breast, prostate, and gynecologic cancers. This episode offers a compelling narrative on the evolving immune system's role in tumor aggressiveness and resistance to standard care, offering a new lens for addressing health inequities. Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts

Host: Darryl S. Chutka, M.D. Guests: Jesse D. Bracamonte, D.O., Casey Martinez, Kiyan Heybati If you’re a physician, there are several events during your medical journey that you’ll always remember, receiving your letter of acceptance for medical school, medical school graduation and Match Day. For those of you who aren’t physicians, Match Day is a very exciting day for medical students. It represents the day students learn where they’ll be doing their residency training. It’s a complicated process that uses an algorithm to match students and residency positions. But what happens if a student doesn’t match with a residency program, what are their options? What do residency programs consider when ranking the numerous student candidates? What are some common mistakes students make during the match process and how can students maximize their chances of matching with one of their top residency choices? These are questions I’ll be asking my guests, Jesse D. Bracamonte, D.O., a family physician and Associate Dean of Student Affairs at the Arizona campus of the Mayo Clinic, as well as Casey Martinez and Kiyan Heybati, both senior medical students from the Mayo Clinic Alix School of Medicine. Our topic of discussion for this podcast will be “Navigating the Match: What Every Medical Student Should Know”. Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts

Host: Denise M. Dupras, M.D., Ph.D. Guest: John R. Giudicessi, M.D., Ph.D. Dr. Giudicessi, a leader in cardiovascular genetics and gene therapy research, discusses the latest advancements in understanding and treating genetic arrhythmias and cardiomyopathies. This episode provides a comprehensive look at how genetics is revolutionizing cardiovascular care, empowering physicians to offer more precise, patient-centered treatments. Dr. Giudicessi’s insights underscore the transformative potential of genetic research in improving outcomes for patients with inheritable cardiovascular diseases. Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts

Host: Darryl S. Chutka, M.D. Guest: John W. Wilson, M.D. Tuberculosis remains a significant health concern. Globally, in 2023, an estimated 10 million individuals developed active tuberculosis and over one million died of the disease. In the U.S., just under 10, 000 individuals in the U.S. were diagnosed with TB, representing an increase over 2022. While tuberculosis remains a treatable disease, it’s important to suspect and recognize those who may have it. A class 5 tuberculosis case is part of a TB classification system and refers to a suspected tuberculosis infection that requires further investigation. Symptoms may or may not be present and these patients may have an active TB case that could be contagious. This podcast is about class 5 tuberculosis cases, and my guest is infectious disease specialist, John W. Wilson, M.D., from the Mayo Clinic. Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts